Chia Tai Tianqing Pharmaceutical Group Co. Ltd.

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Chia Tai Tianqing Pharmaceutical Group (CTTQ) is one of the leading R & D focused integrated pharma companies in China with more than 10,000 employees. Its product pipeline covers broad therapeutic areas, including oncology, liver diseases, respiratory, diabetes, and cardiovascular diseases. It has strong drug R & D capabilities and its product pipeline has been consistently recognized as one of the top five in China.

Its parent company Sino Biopharmaceutical Ltd. has been listed on the Hong Kong Exchange (stock #1177) for almost two decades. It ranks 42nd on Pharm Exec’s 2019 Global Top 50, the highest ranking for any China-based pharma.
Ticker:
1177
Exchange:
Hong Kong Exchange
Company Type:
Not Provided
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
China
Year Founded:
1969
Main Therapeutic Focus:
Lead Product in Development:
Anlotinib
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
5
Speaker
photo
Chief Representative
CTTQ